Digital Imaging Processing Core
数字图像处理核心
基本信息
- 批准号:7214539
- 负责人:
- 金额:$ 30.89万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-12-01 至 2012-03-31
- 项目状态:已结题
- 来源:
- 关键词:AdministratorAmendmentAnimalsArchivesAuthorization documentationBackBiological MarkersBudgetsCell LineCellsClinical TrialsDataData SetData Storage and RetrievalDatabasesDevelopment, OtherDiffusionDirect CostsDisclosureEquipmentFeesFreedomFundingFutureGoalsHeadHealthHistologyHumanHuman ResourcesImageImage AnalysisImplantInpatientsInstructionInvestigationLast NameLeadLesionLocationMagnetic Resonance ImagingMaintenanceMalignant neoplasm of brainMapsMethodsMichiganModelingMultimodal ImagingNamesNoiseNumbersOutpatientsPatient CarePatientsPerfusionPositioning AttributePrincipal InvestigatorProtocols documentationPublishingRegistriesResearchResearch PersonnelResolutionRoleSamplingScanningSliceSoftware ToolsSpecific qualifier valueSystemTAF8 geneTechniquesTestingTherapeuticTranslatingTravelUniversitiesWagesWeightanalytical toolbasecostdata integritydigital imagingfallshuman embryonic stem cellhuman studyimage processingimage registrationin vivomethod developmentprogramsresponsesizetooltumor
项目摘要
Core C: Digital Image Processing
The goals of the Digital Image Processing Core are to continue provide analytic tools for all projects. These
unique image analysis tools are necessary for unbiased, accurate, quantitative analysis of temporal
volumetric changes in single and multimodal MRI data sets of lab animals and human patients.
Currently all MRI acquisitions independent of weightings for all interval exams of both animal and human
studies are fully automatically registered to a "reference" data set in the first exam typically using a rotate-
translate geometry model; this is a multimodality registration problem using existing software tools. Typically
a T1-weighted, post-Gad sequence, is used as the reference for registering all successive interval exam
sets. B1-field corrections have been found to be unnecessary thus far. In cases where the acquisitions
involve high gradient fields such as those used for diffusion or perfusion weighted imaging, registrations are
accomplished using a full affine model to support correction of shears caused by the gradients. Currently all
human scan data including both original acquisitions and registered datasets, as well as animal backups, are
stored on the Core's disk system. In the future all animal scans will be likewise stored on the Core's disks
which can be accessed via TCP/IP or SAMBA protocols over 100 Mb ethernet. Of course the Core is
responsible for maintaining data integrity and backup.
The core will also develop the ability to track the positions of voxels within treated lesions across interval
exams using high degree of freedom warpings. This facility for both animal and human imaging will support
further investigation of the role of the apparent diffusion coefficient (ADC) as well as other parameters, e.g.
perfusion, as potentially early indicators of therapeutic response. Additionally in the A1 amendment this
Core demonstrated the ability to map histology back to in vivo MRI voxels for animals (where whole head ex
vivo MRI acquisitions are possible) using only intrinsic scan information (i.e. no implanted fiducials of any
kind).
Pub. Health: Overall, this research effort willprovide therationale for initiation of clinical trials with
combinations of molecularly targeted therapies for the treatment of malignant brain tumors. In addition,
imaging biomarkers for early assessment of treatment response will be identified and validated which will
lead to individualization of patient treatment.
University of Michigan
Ann Arbor, Michigan
PHS 398(Rev. 09/04) Page 3/V Form Page 2
Principal Investigator/Program Director (Last, First, Middle): ROSS, Brian D.
KEY PERSONNEL. See instructions. Usecontinuation pages as needed to provide the required information in the format shown below.
Start with Principal Investigator. List all other key personnel in alphabetical order, last name first.
Name eRA Commons User Name Organization Role on Project
Meyer, Charles Cmeyer University of Michigan Core Director
Bland, Peyton University of Michigan Co-Investigator
OTHER SIGNIFICANT CONTRIBUTORS
Name Organization Role on Project
Human Embryonic Stem Cells ^ No [~1 Yes
If the proposed project involves human embryonic stem cells, list below the registration number of the specific cell llne(s) from the following list:
http://stemcells.nih.gov/reaistrv/index.asp. Usecontinuationpages asneeded.
If a specific line cannot be referenced at thistime, includea statement that one from the Registry will be used.
Cell Line
Disclosure Permission Statement Applicable toSBIR/STTR Onlv. See SBIR/STTR instructions. Q Yes Q No
PHS 398 (Rev. 09/04) Page 31$" Form Page 2-continued
Number the following pages consecutively throughout
the application. Do not use suffixes such as 4a, 4b.
Principal Investigator/Program Director (Last, first, middle):
DETAILED BUDGET FOR INITIAL BUDGET PERIOD
DIRECT COSTS ONLY Meyer/Core C
PERSONNEL (Applicant organization only) %
TYPE EFFORT INST.
ROLE ON
APPT. ON BASE
NAME PROJECT (months) PROJ. SALARY
Core
Meyer, Charles Director 12 15% $160,680
Co-lnv.
Bland, Peyton 12 25% $95,790
System
Laderach, Gary Administrator 12 5% $71,028
Programmer
Geng, Hairong Analyst 12 100% $53,250
Programmer
(TBN) Technical 12 100% $50,000
GSRA
Eng. GSRA (TBN) 12 100% $23,422
SUBTOT0.1 " "^
CONSULTANT COSTS
EQUIPMENT (Itemize)
Purchased in Years 2 & 3
SUPPLIES (Itemize bycategory)
Mag Tape $500
TRAVEL
1 -2 Trips/year for Core Director
PATIENT CARE COSTS INPATIENT
OUTPATIENT
ALTERATIONS AND RENOVATIONS (Itemize bycategory)
OTHER EXPENSES (Itemize bycategory)
GSRA Tuition & Fees $14,772 (Fall & Winter)
Maintenance Fees $3,000
CONSORTIUM/CONTRACTUAL COSTS
Ross, Brian D.
FROM THROUGH
12/1/2006 11/30/2007
DOLLAR AMOUNT REQUESTED (omit cents)
SALARY FRINGE .
REQUESTED BENEFITS TOTALS
$24,102 $7,231 $31,333
$23,948 $7,184 $31,132
$3,551 $1,065 $4,616
$53,250 $15,975 $69,225
$50,000 $15,000 $65,000
$23,422 $7,027 $30,449
$178,273 $53,482 $231,755 I
$500
$1,200
$17,772
DIRECT COSTS
SUBTOTAL DIRECT COSTS FOR INITIAL BUDGET PEF (Item 7a, FacePage) $
251,227
CONSORTIUM/CONTRACTUAL COSTS | FACILITIES AND ADMINISTRATION COSTS!
TOTAL DIRECTCOSTS FOR INITIAL BUDGET PERIOD $ I
* 251 ,227 |
SBIR/STTR Only: FEE REQUESTED
PHS 398 (Rev. 09/04) Page Form Page 4
核心C:数字图像处理
数字图像处理核心的目标是继续为所有项目提供分析工具。这些
独特的图像分析工具对于时间的公正、准确、定量分析是必要的
实验动物和人类患者的单模态和多模态 MRI 数据集的体积变化。
目前,所有 MRI 采集均独立于动物和人类所有间隔检查的权重
在第一次考试中,研究会完全自动注册到“参考”数据集,通常使用旋转
翻译几何模型;这是使用现有软件工具的多模态注册问题。通常
T1 加权后 Gad 序列用作注册所有连续间隔检查的参考
套。到目前为止,B1 场校正已被发现是不必要的。在收购的情况下
涉及高梯度场,例如用于扩散或灌注加权成像的场,配准是
使用完整的仿射模型来支持由梯度引起的剪切的校正。目前所有
人体扫描数据,包括原始采集数据和注册数据集,以及动物备份
存储在Core的磁盘系统上。将来所有动物扫描结果都将同样存储在 Core 的磁盘上
可以通过 100 Mb 以太网上的 TCP/IP 或 SAMBA 协议进行访问。当然核心是
负责维护数据完整性和备份。
该核心还将开发跨时间间隔跟踪治疗病变内体素位置的能力
使用高自由度扭曲的考试。该动物和人类成像设施将支持
进一步研究表观扩散系数 (ADC) 以及其他参数的作用,例如
灌注,作为治疗反应的潜在早期指标。此外,在 A1 修正案中,
Core 展示了将组织学映射回动物体内 MRI 体素的能力(其中整个头部前
体内 MRI 采集是可能的)仅使用内在扫描信息(即没有植入任何的基准点)
种类)。
酒吧。健康:总体而言,这项研究工作将为启动临床试验提供理论依据
用于治疗恶性脑肿瘤的分子靶向疗法的组合。此外,
将识别和验证用于早期评估治疗反应的成像生物标志物,这将
从而实现患者治疗的个体化。
密歇根大学
密歇根州安娜堡
PHS 398(Rev. 09/04) 第 3 页/V 表格第 2 页
首席研究员/项目总监(最后、第一、中间):ROSS, Brian D.
关键人员。请参阅说明。根据需要使用连续页面以如下所示的格式提供所需信息。
从首席研究员开始。按字母顺序列出所有其他关键人员,姓氏在前。
名称 eRA Commons 用户名 项目中的组织角色
Meyer, Charles Cmeyer 密歇根大学核心主任
布兰德,佩顿密歇根大学联合研究员
其他重要贡献者
名称 组织在项目中的角色
人类胚胎干细胞 ^ 否 [~1 是
如果拟议项目涉及人类胚胎干细胞,请在下面列出特定细胞系的注册号:
http://stemcells.nih.gov/reaistrv/index.asp。根据需要使用续页。
如果此时无法引用特定行,请包含一条将使用注册表中的行的声明。
细胞系
披露许可声明适用于 SBIR/STTR Onlv。请参阅 SBIR/STTR 说明。问 是 Q 否
PHS 398(修订版 09/04)第 31 页 $" 表格第 2 页 - 续
对接下来的页码进行连续编号
该应用程序。请勿使用 4a、4b 等后缀。
首席研究员/项目主任(最后、第一个、中间):
初始预算期的详细预算
仅直接成本 Meyer/Core C
人员(仅限申请组织)%
类型 努力 INST。
角色
PPT。基地
名称 项目(月) 项目。薪水
核
查尔斯·迈耶 董事 12 15% $160,680
联合投资。
佩顿·布兰德 12 25% $95,790
系统
加里·拉德拉赫 管理员 12 5% $71,028
程序员
耿海荣 分析师 12 100% $53,250
程序员
(TBN) 技术 12 100% $50,000
GSRA
工程师。 GSRA (TBN) 12 100% $23,422
SUBTOT0.1“”^
顾问费用
设备(逐项列出)
第 2 年和第 3 年购买
用品(按类别逐项列出)
磁力胶带 500 美元
旅行
核心总监每年 1 -2 次出差
住院患者护理费用
门诊病人
改建和翻新(按类别分项)
其他费用(按类别分项)
GSRA 学杂费 $14,772(秋季和冬季)
维护费 $3,000
财团/合同成本
罗斯,布莱恩·D.
从始至终
2006年12月1日 2007年11月30日
要求的美元金额(省略美分)
工资边缘。
要求的福利总计
$24,102 $7,231 $31,333
$23,948 $7,184 $31,132
$3,551 $1,065 $4,616
$53,250 $15,975 $69,225
$50,000 $15,000 $65,000
$23,422 $7,027 $30,449
$178,273 $53,482 $231,755 我
500 美元
1,200 美元
$17,772
直接成本
初始预算 PEF 直接成本小计(第 7a 项,FacePage) $
251,227
财团/合同成本|设施和管理费用!
初始预算期的直接成本总额 $ I
* 251,227 |
仅限 SBIR/STTR:需要付费
PHS 398(修订版 09/04)页面表格第 4 页
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Charles Raymond Meyer其他文献
Charles Raymond Meyer的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Charles Raymond Meyer', 18)}}的其他基金
AUTOMATIC 3D REGISTRATION FOR ENHANCED CANCER MANAGEMENT
自动 3D 配准以增强癌症管理
- 批准号:
6608879 - 财政年份:2002
- 资助金额:
$ 30.89万 - 项目类别:
Automatic Three Dimensional (3D) Registration for Enhanced Cancer Management
自动三维 (3D) 配准以增强癌症管理
- 批准号:
8445391 - 财政年份:2002
- 资助金额:
$ 30.89万 - 项目类别:
Automatic Three Dimensional (3D) Registration for Enhanced Cancer Management
自动三维 (3D) 配准以增强癌症管理
- 批准号:
8234852 - 财政年份:2002
- 资助金额:
$ 30.89万 - 项目类别:
Early Estimation of Breat Tumor Response to Therapy
乳腺肿瘤治疗反应的早期估计
- 批准号:
8376470 - 财政年份:2002
- 资助金额:
$ 30.89万 - 项目类别:
AUTOMATIC 3D REGISTRATION FOR ENHANCED CANCER MANAGEMENT
自动 3D 配准以增强癌症管理
- 批准号:
7116974 - 财政年份:2002
- 资助金额:
$ 30.89万 - 项目类别:
Automatic Three Dimensional (3D) Registration for Enhanced Cancer Management
自动三维 (3D) 配准以增强癌症管理
- 批准号:
7611736 - 财政年份:2002
- 资助金额:
$ 30.89万 - 项目类别:
Early Estimation of Breat Tumor Response to Therapy
乳腺肿瘤治疗反应的早期估计
- 批准号:
8445392 - 财政年份:2002
- 资助金额:
$ 30.89万 - 项目类别:
Automatic Three Dimensional (3D) Registration for Enhanced Cancer Management
自动三维 (3D) 配准以增强癌症管理
- 批准号:
8376476 - 财政年份:2002
- 资助金额:
$ 30.89万 - 项目类别:
Automatic Three Dimensional (3D) Registration for Enhanced Cancer Management
自动三维 (3D) 配准以增强癌症管理
- 批准号:
7802144 - 财政年份:2002
- 资助金额:
$ 30.89万 - 项目类别:
AUTOMATIC 3D REGISTRATION FOR ENHANCED CANCER MANAGEMENT
自动 3D 配准以增强癌症管理
- 批准号:
6932488 - 财政年份:2002
- 资助金额:
$ 30.89万 - 项目类别:
相似海外基金
Reserch on the theory and practice of Unconstitutional Constitutional Amendment
违宪修宪理论与实践研究
- 批准号:
22K01142 - 财政年份:2022
- 资助金额:
$ 30.89万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Immobilizing vanadium with nano-oxide and biochar combined amendment and investigating the fate of amendment-vanadium complexes at varying geochemical environments of soils.
用纳米氧化物和生物炭组合改良剂固定钒,并研究改良剂-钒络合物在不同土壤地球化学环境下的命运。
- 批准号:
DDG-2022-00020 - 财政年份:2022
- 资助金额:
$ 30.89万 - 项目类别:
Discovery Development Grant
Biochar as a Soil Amendment for Revitalizing Stockpiled Soils and Facilitating Carbon Sequestration at an Oilsands Lease, Christina Lake, Alberta
生物炭作为土壤改良剂,可恢复阿尔伯塔省克里斯蒂娜湖油砂租地的储存土壤并促进碳封存
- 批准号:
561419-2020 - 财政年份:2022
- 资助金额:
$ 30.89万 - 项目类别:
Applied Research and Development Grants - Level 2
Policy framing and its legislative consequence: A comparative analysis of Copyright Act Amendment in Korea and Japan
政策框架及其立法后果:韩日著作权法修正案的比较分析
- 批准号:
22K01648 - 财政年份:2022
- 资助金额:
$ 30.89万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Efficient utilization of biochar for water remediation and soil amendment - towards a circular economy
有效利用生物炭进行水体修复和土壤改良——迈向循环经济
- 批准号:
2747765 - 财政年份:2021
- 资助金额:
$ 30.89万 - 项目类别:
Studentship
Developing a New Sustainable Product: Wood Ash Recycling as Soil Amendment
开发新的可持续产品:木灰回收作为土壤改良剂
- 批准号:
570816-2021 - 财政年份:2021
- 资助金额:
$ 30.89万 - 项目类别:
Applied Research and Development Grants - Level 1
Biochar as a Soil Amendment for Revitalizing Stockpiled Soils and Facilitating Carbon Sequestration at an Oilsands Lease, Christina Lake, Alberta
生物炭作为土壤改良剂,可恢复阿尔伯塔省克里斯蒂娜湖油砂租地的储存土壤并促进碳封存
- 批准号:
561419-2020 - 财政年份:2021
- 资助金额:
$ 30.89万 - 项目类别:
Applied Research and Development Grants - Level 2
Rock dust from mine waste as a natural media amendment in forest reclamation and the production of high value agronomic and horticultural crops
矿山废料中的岩尘作为森林开垦和高价值农业和园艺作物生产中的天然介质改良剂
- 批准号:
531858-2018 - 财政年份:2021
- 资助金额:
$ 30.89万 - 项目类别:
Collaborative Research and Development Grants
Efficient utilization of biochar for water remediation and soil amendment towards a circular economy
有效利用生物炭进行水修复和土壤改良,实现循环经济
- 批准号:
BB/W510361/1 - 财政年份:2021
- 资助金额:
$ 30.89万 - 项目类别:
Training Grant
North Carolina Occupational Health Surveillance Program (Budget Amendment)
北卡罗来纳州职业健康监测计划(预算修正案)
- 批准号:
10464873 - 财政年份:2021
- 资助金额:
$ 30.89万 - 项目类别: